Related Experiment Video
Updated: Oct 14, 2025

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Macrophage Regulation of the Development of Castration-Resistant Prostate Cancer
Haider Al-Janabi1, Claire E Lewis2
1Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, United Kingdom.
Tumor-associated macrophages drive prostate cancer resistance to androgen deprivation therapy (ADT) by transferring cholesterol to cancer cells. This cholesterol fuels androgen biosynthesis, reactivating androgen receptors and promoting tumor regrowth during ADT.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Androgen deprivation therapy (ADT) is a primary treatment for prostate cancer.
- Tumor resistance to ADT leads to cancer progression and necessitates alternative treatments.
- Tumor-associated macrophages (TAMs) are implicated in resistance to various anti-cancer therapies.
Purpose of the Study:
- To elucidate a novel mechanism by which TAMs contribute to prostate tumor resistance during ADT.
- To investigate the role of cholesterol metabolism in TAM-mediated ADT resistance.
Main Methods:
- The study examined the interaction between TAMs and prostate cancer cells under ADT conditions.
- Cholesterol levels in TAMs and cancer cells were assessed.
- Mechanisms of cholesterol transfer and its impact on androgen biosynthesis were investigated.
Main Results:
- Macrophages within prostate tumors accumulate significant amounts of cholesterol during ADT.
- Cholesterol is transferred from TAMs to prostate cancer cells.
- This transferred cholesterol serves as a precursor for androgen biosynthesis within cancer cells, activating androgen receptors.
Conclusions:
- A novel mechanism of ADT resistance in prostate cancer is identified, involving cholesterol transfer from TAMs to cancer cells.
- This process reactivates androgen receptor signaling, driving tumor proliferation despite ADT.
- Targeting this cholesterol-mediated pathway could offer new therapeutic strategies for overcoming ADT resistance in prostate cancer.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019